Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Vila-Corcoles, I. Hospital-Guardiola, T. Rodriguez-Blanco, O. Ochoa-Gondar, M. M. Juarez-Laiz, Study Group EVAN-50 (Tarragona, Barcelona, Spain). Clinical effectiveness of pneumococcal vaccination against nonbacteremic pneumonia in people over 50 years. Eur Respir J 2008; 32: Suppl. 52, 2260

Member's Comments

No comment yet.

Related content which might interest you: The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012 Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects Source: Eur Respir J 2005; 26: 1086-1091 Year: 2005 Characteristics of patients with serotype 5 pneumococcal pneumonia Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020 Vaccination rates against pneumococcal and influenza infection in hospitalized cardiologic and pneumologic patients need to be improved. Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer Year: 2018 Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine Source: Eur Respir J 2013; 42: 1595-1603 Year: 2013 Efficacy of influenza and pneumococcal vaccinations among patients with COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly Source: Eur Respir J 2010; 36: 608-614 Year: 2010 Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma Year: 2013 Influenza vaccination is associated with reduced severity of community-acquired pneumonia Source: Eur Respir J 2011; 37: 147-153 Year: 2011 Cost and outcomes of pneumococcal community-acquired pneumonia among adults in the United Kingdom Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia Source: Eur Respir J 2006 Oct 01;28(4):816-823 Year: 2006 Complicated pneumococcal pneumonia in adults Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Outcome of influenza vaccination in elderly with pneumonia Source: International Congress 2019 – Airway infection in COPD Year: 2019 Evolution of antimicrobial resistance trends in the last five years in patients with bacteremic Pneumococcal community-acquired pneumonia (CAP-SP) Source: Eur Respir J 2005; 26: Suppl. 49, 639s Year: 2005 Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia Source: Eur Respir J 2010; 36: 1073-1079 Year: 2010 Influenza and pneumococcal vaccination in patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany Source: Eur Respir J, 59 (2) 2102432; 10.1183/13993003.02432-2021 Year: 2022 Clinical presentations and serotypes causing invasive pneumococcal disease in adults vaccinated with the 23-valent polysaccharide pneumococcal vaccine (PPV23) in Spain. The ODIN study (2010-2013) Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014